MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$40,992K
Prepaid expenses and
other current assets
$2,531K
Research and development
incentives receivables
$1,497K
Property and equipment,
at cost
$1,222K
Total current assets
$45,020K
Intangible assets, net
$516K
Operating lease
right-of-use assets, net
$244K
Property and equipment,
net
$137K
Less accumulated
depreciation
$1,085K
Total assets
$45,917K
Total liabilities and
shareholders' equity
$45,917K
Total shareholders'
equity
$40,916K
Total liabilities
$5,001K
Accumulated deficit
-$501,018K
Accumulated other
comprehensive loss
-$10,823K
Additional paid-in capital
$549,622K
Total current
liabilities
$4,302K
Other non-current
liabilities
$661K
Warrant liabilities -
non current
$38K
Ordinary shares, par
value 0.003 per share...
$3,135K
Accrued expenses
$2,026K
Accounts payable
$1,333K
Other current
liabilities
$741K
Operating lease
liabilities - current
$202K
Back
Back
Balance Sheet
source: myfinsight.com
Mereo BioPharma Group plc (MREO)
Mereo BioPharma Group plc (MREO)